PAN-CANCER PROFILES OF BRAIN METASTASES: PRIORITIZATION OF THERAPEUTIC TARGETS

被引：0

作者：

Ferguson, Sherise ^{[1
]}

Zheng, Siyuan ^{[2
]}

Xiu, Joanne ^{[3
]}

Zhou, Shouhao ^{[4
]}

Khasraw, Mustafa ^{[5
]}

Brastianos, Priscilla K. ^{[6
]}

Kesari, Santosh ^{[7
]}

Hu, Jethro ^{[8
]}

Rudnick, Jeremy ^{[8
]}

Salacz, Michael ^{[9
]}

Piccioni, David ^{[10
]}

Suyun, Huang ^{[1
]}

Davies, Micheal ^{[11
]}

Glitza, Isabella ^{[11
]}

Heymach, John ^{[12
]}

Zhang, Jianjun ^{[12
]}

Ibrahim, Nuhad ^{[13
]}

de Groot, John ^{[14
]}

McCarty, Joseph ^{[1
]}

O'Brien, Barbara J. ^{[14
]}

Sawaya, Raymond ^{[1
]}

Verhaak, Roel ^{[15
]}

Reddy, Sandeep ^{[3
]}

Priebe, Waldemar ^{[16
]}

Spetzler, David ^{[3
]}

Heimberger, Amy ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Genome Med, Houston, TX 77030 USA

[3] Caris Life Sci, Phoenix, AZ USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[5] Univ Sydney, Camperdown, NSW, Australia

[6] Harvard Med Sch, Massachussetts Gen Hosp, Boston, MA USA

[7] Pacific Neurosci Inst, Santa Monica, CA USA

[8] Cedars Sinai Med Ctr, Neurooncol Program, Los Angeles, CA 90048 USA

[9] Univ Kansas, Kansas City, KS USA

[10] Univ Calif San Diego, San Diego, CA 92103 USA

[11] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA

[12] Univ Texas MD Anderson Canc Ctr, Dept Thorac Oncol, Houston, TX 77030 USA

[13] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

[14] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA

[15] Jackson Lab, Farmington, CT USA

[16] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA

来源：

NEURO-ONCOLOGY | 2017年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CMET-09

引用

页码：40 / 41

页数：2

共 50 条

[41] Pan-Cancer Analysis of the Solute Carrier Family 39 Genes in Relation to Oncogenic, Immune Infiltrating, and Therapeutic Targets
Qu, Yi-Yuan
Guo, Rong-Yan
Luo, Meng-Ling
Zhou, Quan
FRONTIERS IN GENETICS, 2021, 12
[42] A pan-cancer study of spalt-like transcription factors 1/2/3/4 as therapeutic targets
Ma, Ting
Shi, Shanping
Jiang, Haizhong
Chen, Xianwu
Xu, Dingli
Ding, Xiaoyun
Zhang, Hongyan
Xi, Yang
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2021, 711
[43] A pan-cancer analysis of EphA family gene expression and its association with prognosis, tumor microenvironment, and therapeutic targets
Cui, Zhe
Liu, Chengwang
Wang, Xuechao
Xiang, Yiping
FRONTIERS IN ONCOLOGY, 2024, 14
[44] Pan-cancer analysis reveals copper transporters as promising potential targets
Li, Yueqin
Yu, Zhen
HELIYON, 2024, 10 (17)
[45] Considering molecular alterations as pan-cancer tissue-agnostic targets
Adashek, Jacob J.
Kato, Shumei
Sicklick, Jason K.
Lippman, Scott M.
Kurzrock, Razelle
NATURE CANCER, 2023, 4 (12) : 1622 - 1626
[46] Considering molecular alterations as pan-cancer tissue-agnostic targets
Jacob J. Adashek
Shumei Kato
Jason K. Sicklick
Scott M. Lippman
Razelle Kurzrock
Nature Cancer, 2023, 4 : 1622 - 1626
[47] A pan-cancer atlas
Nawy, Tal
NATURE METHODS, 2018, 15 (06) : 407 - 407
[48] A pan-cancer atlas
Tal Nawy
Nature Methods, 2018, 15 : 407 - 407
[49] Therapeutic targets for bone metastases in breast cancer
Philippe Clézardin
Breast Cancer Research, 13
[50] Therapeutic targets for bone metastases in breast cancer
Clezardin, Philippe
BREAST CANCER RESEARCH, 2011, 13 (02):

← 1 2 3 4 5 →